2,2,2-Trichloro-1-(4-iodo-1h-pyrrol-2-yl)ethan-1-one, 95%, 5g

1-(4,5,6-trimethylpyridin-3-yl)methanamine, 95.0%, 250mg

ROTI®Cell RPMI-1640

tert-Butyl 4-pivalamidopiperidine-1-carboxylate, 95.0%, 1g

(R)-3-(tert-Butyl)-4-(2,6-diphenoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 100mg

(E)-3-(2-Methylpyridin-4-yl)acrylic acid, 98%, 500mg

5-Bromo-2-isopropylthiazole, 97%, 100mg

Colonna capillare per GC ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.25 µm, 1 Pezzo(i)

benzyl N-(2-carbamoylethyl)carbamate, 95.0%, 5g

1-(2-Chlorophenyl)piperazin-2-one, 95.0%, 250mg

Benzohydrazide, 98.0%, 25g

4-Bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide, 95%, 1g

2-Bromopyrimidine-5-carboxylic acid, 95.0%, 50mg